What are the impacts of psilocybin on tobacco addiction?
Story continues below
This advertisement has not loaded yet, but your article continues below.
That question has led to Johns Hopkins Medicine receiving its first National Institutes of Health (NIH) grant to directly investigate the therapeutic effects of a classic psychedelic in more than half a century.
The near US$4 million ($4.9 million) grant will fund a multi-site, three-year study led by Hopkins Medicine. The University of Alabama at Birmingham and New York University will also take part in the research.
“The historical importance of this grant is monumental,” principal investigator Matthew Johnson said in a statement. “We knew it was only a matter of time before the NIH would
Read full article on The Growth Op
